財(cái)聯(lián)社9月30日電,默沙東臨床試驗(yàn)數(shù)據(jù)顯示,在針對(duì)新確診肺動(dòng)脈高壓患者的3期HYPERION研究中,與安慰劑組相比,Winrevair?可顯著降低臨床惡化事件風(fēng)險(xiǎn)達(dá)76%。
特別聲明:以上內(nèi)容(如有圖片或視頻亦包括在內(nèi))為自媒體平臺(tái)“網(wǎng)易號(hào)”用戶上傳并發(fā)布,本平臺(tái)僅提供信息存儲(chǔ)服務(wù)。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.